FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CLARAVIS (isotretinoin) by Teva Pharmaceuticals USA, Inc., under ANDA076135.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Claravis (isotretinoin)

Snippet

SUPPL AP for CLARAVIS (ISOTRETINOIN)